Bile acid metabolism involved in the beneficial effects of Dangui Shaoyao San via gut microbiota in the treatment of CCl4 induced hepatic fibrosis

Bioactive polysaccharides promote gut immunity via different ways

(2023) Xincheng Wu et al.   Food & Function

Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of Coriobacterium, Atopobium, Coprococcus and Veillonella dispar may be a new method for HCC diagnosis

(2023) Wenqian Xu et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway

(2023) Xiaowei Sun et al.   Frontiers in Pharmacology

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis

(2023) Juanjuan Wang et al.   Cells

Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

(2023) Qian Huang et al.   BMC Complementary Medicine and Therapies

Marine Chitosan-Oligosaccharide Ameliorated Plasma Cholesterol in Hypercholesterolemic Hamsters by Modifying the Gut Microflora, Bile Acids, and Short-Chain Fatty Acids

(2023) Abdullah Abdo et al.   Nutrients

Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease

(2023) Karly E. Masse et al.   Frontiers in Endocrinology

Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions

(2023) Jayashi Rajapakse et al.   Gut Microbes

The effect of increasing intestinal short‐chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: A systematic review

(2022) Keith Pohl et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder

(2022) Ke Fu et al.   BIOMEDICINE & PHARMACOTHERAPY

Interaction of n-3 polyunsaturated fatty acids with host CD36 genetic variant for gut microbiome and blood lipids in human cohorts

(2022) Zelei Miao et al.   CLINICAL NUTRITION

Comprehensive Analysis of Gut Microbiota and Fecal Bile Acid Profiles in Children With Biliary Atresia

(2022) Ting Yang et al.   Frontiers in Cellular and Infection Microbiology

Integrated Serum Pharmacochemistry, Metabolomics, and Network Pharmacology to Reveal the Material Basis and Mechanism of Danggui Shaoyao San in the Treatment of Primary Dysmenorrhea

(2022) Hui Xiong et al.   Frontiers in Pharmacology

Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism

(2022) Cheng Wang et al.   JOURNAL OF ETHNOPHARMACOLOGY

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis

(2021) Pinyi Liu et al.   PHARMACOLOGICAL RESEARCH

Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease

(2021) Chao Sang et al.   JOURNAL OF PROTEOME RESEARCH

Circulating bile acids as a link between the gut microbiota and cardiovascular health: Impact of Prebiotics, probiotics and polyphenol-rich foods

(2021) R.A.G. Pushpass et al.   NUTRITION RESEARCH REVIEWS

Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis

(2021) Ahmad Salhab et al.   GUT

Flavonoid-Modifying Capabilities of the Human Gut Microbiome—An In Silico Study

(2021) Tobias Goris et al.   Nutrients

Danggui-Shaoyao-San Improves Gut Microbia Dysbiosis and Hepatic Lipid Homeostasis in Fructose-Fed Rats

(2021) Jing Yin et al.   Frontiers in Pharmacology

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

(2021) Scott L. Friedman et al.   HEPATOLOGY

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis

(2021) Miao Yan et al.   Frontiers in Pharmacology

Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells

(2021) Eveline Gart et al.   Biomedicines

Modulation of bile acid profile by gut microbiota in chronic hepatitis B

(2020) Xiaolin Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD

(2020) Tien S. Dong et al.   Scientific Reports

Bile acids associate with specific gut microbiota, low‐level alcohol consumption and liver fibrosis in patients with non‐alcoholic fatty liver disease

(2020) Leon A. Adams et al.   LIVER INTERNATIONAL

The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in Nonalcoholic Steatohepatitis

(2020) Rohit Loomba et al.   HEPATOLOGY

Gut Microbiome Contributes to Liver Fibrosis Impact on T Cell Receptor Immune Repertoire

(2020) Qing Liang et al.   Frontiers in Microbiology

Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease

(2019) Jeffrey B. Schwimmer et al.   GASTROENTEROLOGY

Effects of sodium butyrate on intestinal health and gut microbiota composition during intestinal inflammation progression in broilers

(2019) X Zou et al.   POULTRY SCIENCE

Modification effects of SanWei GanJiang Powder on liver and intestinal damage through reversing bile acid homeostasis

(2019) Na Li et al.   BIOMEDICINE & PHARMACOTHERAPY

TLR2/EGFR Are Two Sensors for pBD3 and pEP2C Induction by Sodium Butyrate Independent of HDAC Inhibition

(2019) Xiujing Dou et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease

(2018) Huikuan Chu et al.   GUT

Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD

(2018) Cyrielle Caussy et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis

(2018) Jiyu Zhou et al.   Acta Pharmaceutica Sinica B

New therapeutic concepts in bile acid transport and signaling for management of cholestasis

(2017) Michael Trauner et al.   HEPATOLOGY

Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats

(2015) Jia-Yin Yan et al.   JOURNAL OF ETHNOPHARMACOLOGY

Clinical application of transcriptional activators of bile salt transporters

(2013) Anna Baghdasaryan et al.   MOLECULAR ASPECTS OF MEDICINE

Early weaning increases intestinal permeability, alters expression of cytokine and tight junction proteins, and activates mitogen-activated protein kinases in pigs1

(2012) C. H. Hu et al.   JOURNAL OF ANIMAL SCIENCE

Bile-acid-induced cell injury and protection

(2009) Maria J Perez et al.   WORLD JOURNAL OF GASTROENTEROLOGY